Johnson & Johnson (BSP:JNJB34)
R$ 60.12 0 (0%) Market Cap: 2.18 Til Enterprise Value: 2.27 Til PE Ratio: 24.52 PB Ratio: 5.08 GF Score: 76/100

Johnson & Johnson at Bank of America Global Research Healthcare Conference (Virtual) Transcript

May 11, 2021 / 02:15PM GMT
Release Date Price: R$58.6 (-0.98%)
Robert Adam Hopkins
BofA Securities, Research Division - MD of Equity Research

Okay. Great. Thank you, everybody, for joining us for the next fireside chat as part of our virtual Las Vegas Health Care Conference here. We're absolutely honored and thrilled to announce our next fireside chat is with Ashley McEvoy, who, as everybody knows, leads the J&J's Medical Device business, which obviously is the largest medical device business in the world. And Ashley is, obviously, EVP and Chairman of Medical Devices. So Ashley, I just wanted to sort of formally on behalf of Bank of America, thank you for joining us today, and welcome.

Ashley A. McEvoy
Johnson & Johnson - Executive VP & Worldwide Chairman of Medical Devices

Thank you very much, Bob. My pleasure. Looking forward to engaging in a good discussion.

Robert Adam Hopkins
BofA Securities, Research Division - MD of Equity Research

Yes, absolutely. So we'll just do mostly fireside chat here. And -- so I'll just go ahead with some questions, and we look

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot